Erratum: Identifying Patients With Low Relapse Rate Despite High-Risk Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: Development and Validation of a Clinicopathologic Assay.

François-Clément Bidard, Grégoire Gessain, Thomas Bachelot, Lucie Frechin, Anne Vincent-Salomon, Damien Drubay, Jérôme Lemonnier, Thomas Walter, Frédérique Penault-Llorca, Anne-Laure Martin, Catherine Gaudin, Antoine Bichat, Farah Sassi, Sylvain Berlemont, Mariana Chavez-MacGregor